Course Overview
Dialogues in Diabetes: Major Clinical Trial Results From the 2009 ADA Annual Meeting
Developed in collaboration with The Endocrine Society, this series also includes the AMA-standardized, 3-stage initiative Performance Improvement Strategies in Diabetes Care. Earn 20 AMA PRA Category 1 Credits™ in this certified PI CME initiative.
Overview: In this Webcast, the faculty discuss the design and major results from some of the most notable studies released at the 2009 ADA annual meeting, including VADT, ACCORD, RECORD, and BARI 2D. The relationship between intensive glucose control and cardiovascular disease was studied in both VADT and ACCORD, and neither study showed a significant association. The RECORD trial looked at cardiovascular morbidity and mortality in type 2 diabetes patients taking rosiglitazone compared with a combination of metformin and a sulfonylurea and found no significant difference between the two groups. BARI 2D examined the frequency of cardiovascular events in type 2 diabetes patients with CAD undergoing revascularization (bypass or PCI) compared with those treated with intensive medical therapy. The glycemic control of BARI 2D was designed to test the hypothesis that insulin-sensitization therapy would lead to a reduction of cardiovascular disease.
Faculty
Brian P. McDonough, MD
Chairman
Department of Family Medicine
St. Francis Hospital
Clinical Professor of Family Medicine
Temple University School of Medicine
Philadelphia, PA
Vivian Fonseca, MD
Professor of Medicine and Pharmacology
Tullis Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences Center
New Orleans, LA
Professor of Medicine
Scott & White Healthcare
Texas A&M Health Science Center College of Medicine
Temple, TX
Credits available: A maximum of 0.25 AMA PRA Category 1 Credit™
Types of credit available:
AMA PRA Category 1 Credit™
Expires: 8/5/10
This activity has been approved for AMA PRA Category 1 Credit™
Supported by an educational grant from:
Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or e-mail info@med-iq.com. For technical assistance, please refer to our support manual.
Bookmark These Med-IQ Sites
Med-IQ Specialty Sites
